News Focus
News Focus
Followers 2
Posts 660
Boards Moderated 0
Alias Born 10/30/2004

Re: DewDiligence post# 391

Wednesday, 09/13/2006 6:50:35 PM

Wednesday, September 13, 2006 6:50:35 PM

Post# of 2446
" What I do not think we are likely to see is a standard of care that involves two different injected drugs taken in sequence."

What makes you think this?

"other AMD drug candidates have to aim high, hoping to supplant Lucentis/Avastin as a monotherapy in a substantial fraction of patients."

What better way to aim high than to put your drug on a durable implant?

The obstacle to discovery is the illusion of knowledge.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRDX News